SE370449B
(ar)
|
1970-08-29 |
1974-10-14 |
Philips Nv |
|
JPS5334319B2
(ar)
|
1971-12-28 |
1978-09-20 |
|
|
JPS5616428B2
(ar)
|
1973-04-13 |
1981-04-16 |
|
|
JPS6048972B2
(ja)
|
1975-08-08 |
1985-10-30 |
株式会社日立製作所 |
方向比較搬送保護継電装置
|
JPS5816170B2
(ja)
|
1977-03-16 |
1983-03-30 |
旭化成株式会社 |
乾式画像形成材料
|
US4208479A
(en)
|
1977-07-14 |
1980-06-17 |
Syva Company |
Label modified immunoassays
|
JPS5970B2
(ja)
|
1978-02-10 |
1984-01-05 |
エプソン株式会社 |
小型プリンタの紙送り機構
|
JPS55134615A
(en)
|
1979-04-05 |
1980-10-20 |
Ishigaki Kiko Kk |
Removing device for cake in filter press
|
JPS5912436B2
(ja)
|
1980-08-05 |
1984-03-23 |
ファナック株式会社 |
工業用ロボットの安全機構
|
JPS6022444B2
(ja)
|
1980-11-08 |
1985-06-01 |
日立化成工業株式会社 |
集成マイカ材料,集成マイカプリプレグ材料及び集成マイカ製品
|
US4474893A
(en)
|
1981-07-01 |
1984-10-02 |
The University of Texas System Cancer Center |
Recombinant monoclonal antibodies
|
US4444878A
(en)
|
1981-12-21 |
1984-04-24 |
Boston Biomedical Research Institute, Inc. |
Bispecific antibody determinants
|
JPS58201994A
(ja)
|
1982-05-21 |
1983-11-25 |
Hideaki Hagiwara |
抗原特異的ヒト免疫グロブリンの生産方法
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
GB8607679D0
(en)
|
1986-03-27 |
1986-04-30 |
Winter G P |
Recombinant dna product
|
US6121424A
(en)
|
1991-11-25 |
2000-09-19 |
Enzon, Inc. |
Multivalent antigen-binding proteins
|
WO1988007089A1
(en)
|
1987-03-18 |
1988-09-22 |
Medical Research Council |
Altered antibodies
|
US5004697A
(en)
|
1987-08-17 |
1991-04-02 |
Univ. Of Ca |
Cationized antibodies for delivery through the blood-brain barrier
|
US5322678A
(en)
|
1988-02-17 |
1994-06-21 |
Neorx Corporation |
Alteration of pharmacokinetics of proteins by charge modification
|
US6010902A
(en)
|
1988-04-04 |
2000-01-04 |
Bristol-Meyers Squibb Company |
Antibody heteroconjugates and bispecific antibodies for use in regulation of lymphocyte activity
|
IL89491A0
(en)
|
1988-11-17 |
1989-09-10 |
Hybritech Inc |
Bifunctional chimeric antibodies
|
US5530101A
(en)
|
1988-12-28 |
1996-06-25 |
Protein Design Labs, Inc. |
Humanized immunoglobulins
|
DE3920358A1
(de)
|
1989-06-22 |
1991-01-17 |
Behringwerke Ag |
Bispezifische und oligospezifische, mono- und oligovalente antikoerperkonstrukte, ihre herstellung und verwendung
|
EP0505357B1
(en)
|
1989-12-11 |
1999-03-10 |
Immunomedics, Inc. |
Method for antibody targeting of diagnostic or therapeutic agents
|
TW212184B
(ar)
|
1990-04-02 |
1993-09-01 |
Takeda Pharm Industry Co Ltd |
|
JPH04228089A
(ja)
|
1990-05-15 |
1992-08-18 |
Kanegafuchi Chem Ind Co Ltd |
高カルシウム血症治療・予防剤
|
JPH05184383A
(ja)
|
1990-06-19 |
1993-07-27 |
Dainabotsuto Kk |
二重特異性抗体
|
DK0585287T3
(da)
|
1990-07-10 |
2000-04-17 |
Cambridge Antibody Tech |
Fremgangsmåde til fremstilling af specifikke bindingsparelementer
|
GB9015198D0
(en)
|
1990-07-10 |
1990-08-29 |
Brien Caroline J O |
Binding substance
|
JPH05199894A
(ja)
|
1990-08-20 |
1993-08-10 |
Takeda Chem Ind Ltd |
二重特異性抗体および抗体含有薬剤
|
WO1993012227A1
(en)
|
1991-12-17 |
1993-06-24 |
Genpharm International, Inc. |
Transgenic non-human animals capable of producing heterologous antibodies
|
DK0546073T3
(da)
|
1990-08-29 |
1998-02-02 |
Genpharm Int |
Frembringelse og anvendelse af transgene, ikke-humane dyr, der er i stand til at danne heterologe antistoffer
|
RU2139351C1
(ru)
|
1991-04-25 |
1999-10-10 |
Чугаи Сейяку Кабусики Кайся |
Н- и l-цепи моноклонального антитела рм1 (монат) к рецептору il-6r человека и их v-области, модифицированная монат, его н- и l-цепи и их v-области, cdr- последовательности, днк-последовательности
|
JPH04336051A
(ja)
|
1991-05-10 |
1992-11-24 |
Toshiba Corp |
超音波診断装置
|
JPH05304992A
(ja)
|
1991-06-20 |
1993-11-19 |
Takeda Chem Ind Ltd |
ハイブリッド・モノクローナル抗体および抗体含有薬剤
|
EP0605522B1
(en)
|
1991-09-23 |
1999-06-23 |
Medical Research Council |
Methods for the production of humanized antibodies
|
ES2241710T3
(es)
|
1991-11-25 |
2005-11-01 |
Enzon, Inc. |
Procedimiento para producir proteinas multivalentes de union a antigeno.
|
WO1993011236A1
(en)
|
1991-12-02 |
1993-06-10 |
Medical Research Council |
Production of anti-self antibodies from antibody segment repertoires and displayed on phage
|
US5667988A
(en)
|
1992-01-27 |
1997-09-16 |
The Scripps Research Institute |
Methods for producing antibody libraries using universal or randomized immunoglobulin light chains
|
JPH05203652A
(ja)
|
1992-01-28 |
1993-08-10 |
Fuji Photo Film Co Ltd |
抗体酵素免疫分析法
|
JPH05213775A
(ja)
|
1992-02-05 |
1993-08-24 |
Otsuka Pharmaceut Co Ltd |
Bfa抗体
|
US6749853B1
(en)
|
1992-03-05 |
2004-06-15 |
Board Of Regents, The University Of Texas System |
Combined methods and compositions for coagulation and tumor treatment
|
EP0656941B1
(en)
|
1992-03-24 |
2005-06-01 |
Cambridge Antibody Technology Limited |
Methods for producing members of specific binding pairs
|
US6129914A
(en)
|
1992-03-27 |
2000-10-10 |
Protein Design Labs, Inc. |
Bispecific antibody effective to treat B-cell lymphoma and cell line
|
US5744446A
(en)
|
1992-04-07 |
1998-04-28 |
Emory University |
Hybrid human/animal factor VIII
|
WO1993022332A2
(en)
|
1992-04-24 |
1993-11-11 |
Board Of Regents, The University Of Texas System |
Recombinant production of immunoglobulin-like domains in prokaryotic cells
|
WO1994002602A1
(en)
|
1992-07-24 |
1994-02-03 |
Cell Genesys, Inc. |
Generation of xenogeneic antibodies
|
ZA936260B
(en)
|
1992-09-09 |
1994-03-18 |
Smithkline Beecham Corp |
Novel antibodies for conferring passive immunity against infection by a pathogen in man
|
US5639641A
(en)
|
1992-09-09 |
1997-06-17 |
Immunogen Inc. |
Resurfacing of rodent antibodies
|
GB9313509D0
(en)
|
1993-06-30 |
1993-08-11 |
Medical Res Council |
Chemisynthetic libraries
|
EP0729976A1
(en)
|
1993-11-19 |
1996-09-04 |
Chugai Seiyaku Kabushiki Kaisha |
Reconstituted human antibody against human medulloblastomatous cell
|
EP0731842A1
(en)
|
1993-12-03 |
1996-09-18 |
Medical Research Council |
Recombinant binding proteins and peptides
|
US6214613B1
(en)
|
1993-12-03 |
2001-04-10 |
Ashai Kasei Kogyo Kabushiki Kaisha |
Expression screening vector
|
JP3485266B2
(ja)
|
1994-05-20 |
2004-01-13 |
松下電器産業株式会社 |
プロセッサ
|
US5622701A
(en)
|
1994-06-14 |
1997-04-22 |
Protein Design Labs, Inc. |
Cross-reacting monoclonal antibodies specific for E- and P-selectin
|
WO1996002576A1
(fr)
|
1994-07-13 |
1996-02-01 |
Chugai Seiyaku Kabushiki Kaisha |
Anticorps humain reconstitue contre l'interleukine-8 humaine
|
AU3272695A
(en)
|
1994-08-12 |
1996-03-07 |
Immunomedics Inc. |
Immunoconjugates and humanized antibodies specific for b-cell lymphoma and leukemia cells
|
US6309636B1
(en)
|
1995-09-14 |
2001-10-30 |
Cancer Research Institute Of Contra Costa |
Recombinant peptides derived from the Mc3 anti-BA46 antibody, methods of use thereof, and methods of humanizing antibody peptides
|
DK0783893T3
(da)
|
1994-10-07 |
2012-05-29 |
Chugai Pharmaceutical Co Ltd |
Inhibering af unormal vækst af synovial-celler under anvendelse af il-6-antagonist som aktiv bestanddel
|
EP0791359A4
(en)
|
1994-10-21 |
2002-09-11 |
Chugai Pharmaceutical Co Ltd |
MEDICINE AGAINST IL-6 PRODUCTION IN DISEASES
|
EP1241264A1
(en)
|
1994-12-02 |
2002-09-18 |
Chiron Corporation |
Monoclonal antibodies to colon cancer antigen
|
US6485943B2
(en)
|
1995-01-17 |
2002-11-26 |
The University Of Chicago |
Method for altering antibody light chain interactions
|
BR9604884A
(pt)
|
1995-02-28 |
1998-05-19 |
Procter & Gamble |
Preparação de produtos de bebida não carbonatada com estabilidade microbiana superior
|
US5731168A
(en)
|
1995-03-01 |
1998-03-24 |
Genentech, Inc. |
Method for making heteromultimeric polypeptides
|
DE69637481T2
(de)
|
1995-04-27 |
2009-04-09 |
Amgen Fremont Inc. |
Aus immunisierten Xenomäusen stammende menschliche Antikörper gegen IL-8
|
AU2466895A
(en)
|
1995-04-28 |
1996-11-18 |
Abgenix, Inc. |
Human antibodies derived from immunized xenomice
|
CA2205007C
(en)
|
1995-09-11 |
2010-12-14 |
Masamichi Koike |
Antibody against human interleukin-5 receptor .alpha. chain
|
MA24512A1
(fr)
|
1996-01-17 |
1998-12-31 |
Univ Vermont And State Agrienl |
Procede pour la preparation d'agents anticoagulants utiles dans le traitement de la thrombose
|
ZA976326B
(en)
|
1996-07-19 |
1998-02-03 |
Amgen Inc |
Analogs of cationic proteins.
|
CZ106299A3
(cs)
|
1996-09-26 |
1999-08-11 |
Chugai Seiyaku Kabushiki Kaisha |
Protilátky proti proteinu příbuznému s lidským parathyroidálním hormonem
|
UA76934C2
(en)
|
1996-10-04 |
2006-10-16 |
Chugai Pharmaceutical Co Ltd |
Reconstructed human anti-hm 1.24 antibody, coding dna, vector, host cell, method for production of reconstructed human antibody, pharmaceutical composition and drug for treating myeloma containing reconstructed human anti-hm 1.24 antibody
|
JP3587664B2
(ja)
|
1996-10-04 |
2004-11-10 |
中外製薬株式会社 |
再構成ヒト抗hm1.24抗体
|
WO1998023289A1
(en)
|
1996-11-27 |
1998-06-04 |
The General Hospital Corporation |
MODULATION OF IgG BINDING TO FcRn
|
JPH10165184A
(ja)
|
1996-12-16 |
1998-06-23 |
Tosoh Corp |
抗体、遺伝子及びキメラ抗体の製法
|
US5990286A
(en)
|
1996-12-18 |
1999-11-23 |
Techniclone, Inc. |
Antibodies with reduced net positive charge
|
JP4228089B2
(ja)
|
1997-03-11 |
2009-02-25 |
株式会社ニコン |
過電流検知機構およびそれを用いた電子閃光装置
|
JPH10256223A
(ja)
|
1997-03-11 |
1998-09-25 |
Super Silicon Kenkyusho:Kk |
ウェーハ面取り部の枚葉処理装置
|
US6884879B1
(en)
|
1997-04-07 |
2005-04-26 |
Genentech, Inc. |
Anti-VEGF antibodies
|
US7365166B2
(en)
|
1997-04-07 |
2008-04-29 |
Genentech, Inc. |
Anti-VEGF antibodies
|
FR2761994B1
(fr)
|
1997-04-11 |
1999-06-18 |
Centre Nat Rech Scient |
Preparation de recepteurs membranaires a partir de baculovirus extracellulaires
|
US20020062010A1
(en)
|
1997-05-02 |
2002-05-23 |
Genentech, Inc. |
Method for making multispecific antibodies having heteromultimeric and common components
|
US20030207346A1
(en)
|
1997-05-02 |
2003-11-06 |
William R. Arathoon |
Method for making multispecific antibodies having heteromultimeric and common components
|
ES2246069T3
(es)
|
1997-05-02 |
2006-02-01 |
Genentech, Inc. |
Procedimiento de preparacion de anticuerpos multiespecificos que tienen componentes comunes y multimericos.
|
DE19725586C2
(de)
|
1997-06-17 |
1999-06-24 |
Gsf Forschungszentrum Umwelt |
Verfahren zur Herstellung von Zellpräparaten zur Immunisierung mittels heterologer intakter bispezifischer und/oder trispezifischer Antikörper
|
US6207805B1
(en)
|
1997-07-18 |
2001-03-27 |
University Of Iowa Research Foundation |
Prostate cell surface antigen-specific antibodies
|
US6617156B1
(en)
|
1997-08-15 |
2003-09-09 |
Lynn A. Doucette-Stamm |
Nucleic acid and amino acid sequences relating to Enterococcus faecalis for diagnostics and therapeutics
|
US6342220B1
(en)
|
1997-08-25 |
2002-01-29 |
Genentech, Inc. |
Agonist antibodies
|
US7361336B1
(en)
|
1997-09-18 |
2008-04-22 |
Ivan Bergstein |
Methods of cancer therapy targeted against a cancer stem line
|
EP1020522B1
(en)
|
1997-10-03 |
2007-09-19 |
Chugai Seiyaku Kabushiki Kaisha |
Natural human antibody
|
JPH11118775A
(ja)
|
1997-10-09 |
1999-04-30 |
Canon Inc |
超音波検査装置
|
US6528624B1
(en)
|
1998-04-02 |
2003-03-04 |
Genentech, Inc. |
Polypeptide variants
|
CA2325346A1
(en)
|
1998-04-03 |
1999-10-14 |
Chugai Seiyaku Kabushiki Kaisha |
Humanized antibody against human tissue factor (tf) and process for constructing humanized antibody
|
WO1999054342A1
(en)
|
1998-04-20 |
1999-10-28 |
Pablo Umana |
Glycosylation engineering of antibodies for improving antibody-dependent cellular cytotoxicity
|
GB9809951D0
(en)
|
1998-05-08 |
1998-07-08 |
Univ Cambridge Tech |
Binding molecules
|
JP3445153B2
(ja)
|
1998-06-04 |
2003-09-08 |
富士通株式会社 |
電話番号一時的使用装置及び方法
|
CA2341029A1
(en)
|
1998-08-17 |
2000-02-24 |
Abgenix, Inc. |
Generation of modified molecules with increased serum half-lives
|
WO2000018806A1
(de)
|
1998-09-25 |
2000-04-06 |
Horst Lindhofer |
Bispezifische und trispezifische antikörper, die spezifisch mit induzierbaren oberflächenantigenen als operationelle zielstrukturen reagieren
|
CA2346264A1
(en)
|
1998-10-16 |
2000-04-27 |
Regents Of The University Of California |
Glypicans for the detection and treatment of human carcinoma
|
JP2002531466A
(ja)
|
1998-12-01 |
2002-09-24 |
プロテイン デザイン ラブス, インコーポレイテッド |
γ−インターフェロンに対するヒト化抗体
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
US7183387B1
(en)
|
1999-01-15 |
2007-02-27 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
PL209786B1
(pl)
|
1999-01-15 |
2011-10-31 |
Genentech Inc |
Przeciwciało zawierające wariant regionu Fc ludzkiej IgG1, przeciwciało wiążące czynnik wzrostu śródbłonka naczyń oraz immunoadhezyna
|
DK1156823T3
(da)
|
1999-02-12 |
2009-01-19 |
Scripps Research Inst |
Fremgangsmåder til behandling af tumorer og metastaser ved anvendelse af en kombination af anti-angiogene terapier og immunoterapier
|
US6972125B2
(en)
|
1999-02-12 |
2005-12-06 |
Genetics Institute, Llc |
Humanized immunoglobulin reactive with B7-2 and methods of treatment therewith
|
ES2420835T3
(es)
|
1999-04-09 |
2013-08-27 |
Kyowa Hakko Kirin Co., Ltd. |
Procedimiento para controlar la actividad de las moléculas inmunofuncionales
|
SK782002A3
(en)
|
1999-07-21 |
2003-08-05 |
Lexigen Pharm Corp |
FC fusion proteins for enhancing the immunogenicity of protein and peptide antigens
|
DE60039893D1
(ar)
|
1999-08-23 |
2008-09-25 |
Chugai Pharmaceutical Co Ltd |
|
AT411997B
(de)
|
1999-09-14 |
2004-08-26 |
Baxter Ag |
Faktor ix/faktor ixa aktivierende antikörper und antikörper-derivate
|
JP3606132B2
(ja)
|
1999-10-14 |
2005-01-05 |
Jfeエンジニアリング株式会社 |
超音波探傷方法およびその装置
|
SE9903895D0
(sv)
|
1999-10-28 |
1999-10-28 |
Active Biotech Ab |
Novel compounds
|
HUP0301835A2
(hu)
|
2000-05-03 |
2003-09-29 |
Mbt Munich Biotechnology Ag |
Kationos diagnosztikai, képalkotó és terápiás ágensek, aktivált vaszkuláris helyekkel asszociálódva
|
CA2409991A1
(en)
|
2000-05-24 |
2001-11-29 |
Imclone Systems Incorporated |
Bispecific immunoglobulin-like antigen binding proteins and method of production
|
GB0017635D0
(en)
|
2000-07-18 |
2000-09-06 |
Pharmacia & Upjohn Spa |
Antitumor combined therapy
|
JP2002048867A
(ja)
|
2000-08-07 |
2002-02-15 |
Mitsubishi Heavy Ind Ltd |
音響探査装置
|
MXPA03002161A
(es)
|
2000-09-12 |
2006-03-21 |
Union Carbide Chem Plastic |
Compuestos de polimeros que contienen copolimeros de oxido de alquileno.
|
CN103333860B
(zh)
|
2000-10-06 |
2015-07-08 |
协和发酵麒麟株式会社 |
产生抗体组合物的细胞
|
WO2002040545A2
(en)
|
2000-11-17 |
2002-05-23 |
The Government Of The United States, As Represented By The Secretary Of The Department Of Health And Human Services |
Reduction of the nonspecific animal toxicity of immunotoxins by mutating the framework regions of the fv to lower the isoelectric point
|
US7361343B2
(en)
|
2003-01-21 |
2008-04-22 |
Arius Research Inc. |
Cytotoxicity mediation of cells evidencing surface expression of CD63
|
EP1355919B1
(en)
|
2000-12-12 |
2010-11-24 |
MedImmune, LLC |
Molecules with extended half-lives, compositions and uses thereof
|
JP2005500018A
(ja)
|
2001-04-02 |
2005-01-06 |
アイデック ファーマスーティカルズ コーポレイション |
GnTIIIと同時発現する組換え抗体
|
CN1294148C
(zh)
|
2001-04-11 |
2007-01-10 |
中国科学院遗传与发育生物学研究所 |
环状单链三特异抗体
|
EP1250023A1
(en)
|
2001-04-11 |
2002-10-16 |
Alcatel |
Provision of subscriber QoS guarantees to roaming subscribers
|
US7358054B2
(en)
|
2001-04-13 |
2008-04-15 |
Biogen Idec Ma Inc. |
Antibodies to VLA-1
|
JP3642316B2
(ja)
|
2001-06-15 |
2005-04-27 |
日本電気株式会社 |
化学増幅レジスト用単量体、化学増幅レジスト用重合体、化学増幅レジスト組成物、パターン形成方法
|
DE60228721D1
(en)
|
2001-06-22 |
2008-10-16 |
Chugai Pharmaceutical Co Ltd |
Zellproliferationsinhibitoren mit anti-glypican-3-antikörper
|
DE10136273A1
(de)
|
2001-07-25 |
2003-02-13 |
Sabine Debuschewitz |
Molekulare Marker beim hepatozellulären Karzinom
|
AU2002339845B2
(en)
|
2001-08-03 |
2009-03-26 |
Roche Glycart Ag |
Antibody glycosylation variants having increased antibody-dependent cellular cytotoxicity
|
US20030049203A1
(en)
|
2001-08-31 |
2003-03-13 |
Elmaleh David R. |
Targeted nucleic acid constructs and uses related thereto
|
US7850990B2
(en)
|
2001-10-03 |
2010-12-14 |
Celator Pharmaceuticals, Inc. |
Compositions for delivery of drug combinations
|
JP4778679B2
(ja)
|
2001-10-03 |
2011-09-21 |
セレーター ファーマシューティカルズ インコーポレイテッド |
併用薬剤を送達するための組成物
|
MXPA04003798A
(es)
|
2001-10-25 |
2004-07-30 |
Genentech Inc |
Composiciones de glicoproteina.
|
DE10156482A1
(de)
|
2001-11-12 |
2003-05-28 |
Gundram Jung |
Bispezifisches Antikörper-Molekül
|
EP1462799B1
(en)
|
2001-11-14 |
2011-01-19 |
Kabushiki Kaisha Toshiba |
Ultrasonograph with calculation of ultrasonic wave refraction
|
JP4087098B2
(ja)
|
2001-11-14 |
2008-05-14 |
株式会社東芝 |
超音波検査装置
|
JP3961359B2
(ja)
|
2002-07-18 |
2007-08-22 |
株式会社東芝 |
超音波画像化装置
|
JP2003157075A
(ja)
|
2001-11-22 |
2003-05-30 |
Kawai Musical Instr Mfg Co Ltd |
電子楽器のパラメータ入力装置
|
EP3960855A1
(en)
|
2001-12-28 |
2022-03-02 |
Chugai Seiyaku Kabushiki Kaisha |
Method for stabilizing proteins
|
MXPA04007583A
(es)
|
2002-02-11 |
2005-04-25 |
Genentech Inc |
Variantes de anticuerpo con tasas mas rapidas de asociacion a antigeno.
|
US20040002587A1
(en)
|
2002-02-20 |
2004-01-01 |
Watkins Jeffry D. |
Fc region variants
|
US7317091B2
(en)
|
2002-03-01 |
2008-01-08 |
Xencor, Inc. |
Optimized Fc variants
|
US7662925B2
(en)
|
2002-03-01 |
2010-02-16 |
Xencor, Inc. |
Optimized Fc variants and methods for their generation
|
US20040110226A1
(en)
|
2002-03-01 |
2004-06-10 |
Xencor |
Antibody optimization
|
US20040132101A1
(en)
|
2002-09-27 |
2004-07-08 |
Xencor |
Optimized Fc variants and methods for their generation
|
US8188231B2
(en)
|
2002-09-27 |
2012-05-29 |
Xencor, Inc. |
Optimized FC variants
|
WO2004022597A1
(ja)
|
2002-09-04 |
2004-03-18 |
Chugai Seiyaku Kabushiki Kaisha |
Gpc3の血中可溶化n端ペプチドに対する抗体
|
CA2481658A1
(en)
|
2002-04-09 |
2003-10-16 |
Kyowa Hakko Kogyo Co., Ltd. |
Method of enhancing of binding activity of antibody composition to fcy receptor iiia
|
WO2003087163A1
(fr)
|
2002-04-15 |
2003-10-23 |
Chugai Seiyaku Kabushiki Kaisha |
Procede d'elaboration d'une banque scdb
|
WO2003091424A1
(fr)
|
2002-04-26 |
2003-11-06 |
Chugai Seiyaku Kabushiki Kaisha |
Procede de criblage d'un anticorps agoniste
|
CN100401068C
(zh)
|
2002-05-23 |
2008-07-09 |
阳光溪流女子学院健康科学中心 |
肝细胞癌的诊断
|
EP1510943A4
(en)
|
2002-05-31 |
2007-05-09 |
Celestar Lexico Sciences Inc |
INTERACTION PREDICTION DEVICE
|
US20060088899A1
(en)
|
2002-05-31 |
2006-04-27 |
Alvarez Vernon L |
Combination chemotherapy with chlorotoxin
|
JP2004086862A
(ja)
|
2002-05-31 |
2004-03-18 |
Celestar Lexico-Sciences Inc |
タンパク質相互作用情報処理装置、タンパク質相互作用情報処理方法、プログラム、および、記録媒体
|
EP1517921B1
(en)
|
2002-06-28 |
2006-06-07 |
Domantis Limited |
Dual specific ligands with increased serum half-life
|
DK2314629T4
(da)
|
2002-07-18 |
2023-02-06 |
Merus Nv |
Rekombinant produktion af blandinger af antistoffer
|
US20040086979A1
(en)
|
2002-08-15 |
2004-05-06 |
Dongxiao Zhang |
Humanized rabbit antibodies
|
JP4406607B2
(ja)
|
2002-08-26 |
2010-02-03 |
オンコセラピー・サイエンス株式会社 |
ペプチド及びこれを含む医薬
|
WO2004023145A1
(ja)
|
2002-09-04 |
2004-03-18 |
Perseus Proteomics Inc. |
Gpc3の検出による癌の診断方法
|
AU2002328429A1
(en)
|
2002-09-04 |
2004-03-29 |
Chugai Seiyaku Kabushiki Kaisha |
CONSTRUCTION OF ANTIBODY USING MRL/lpr MOUSE
|
US20060235208A1
(en)
|
2002-09-27 |
2006-10-19 |
Xencor, Inc. |
Fc variants with optimized properties
|
EP1553975B8
(en)
|
2002-09-27 |
2023-04-12 |
Xencor, Inc. |
Optimized fc variants and methods for their generation
|
EP1562972B1
(en)
|
2002-10-15 |
2010-09-08 |
Facet Biotech Corporation |
ALTERATION OF FcRn BINDING AFFINITIES OR SERUM HALF-LIVES OF ANTIBODIES BY MUTAGENESIS
|
ES2744275T3
(es)
|
2002-10-17 |
2020-02-24 |
Genmab As |
Anticuerpos monoclonales humanos contra CD20 para su uso en el tratamiento de esclerosis múltiple
|
WO2004065611A1
(ja)
*
|
2003-01-21 |
2004-08-05 |
Chugai Seiyaku Kabushiki Kaisha |
抗体の軽鎖スクリーニング方法
|
US7223393B2
(en)
|
2003-02-07 |
2007-05-29 |
Pdl Biopharma, Inc |
Amphiregulin antibodies and their use to treat cancer and psoriasis
|
US8388955B2
(en)
|
2003-03-03 |
2013-03-05 |
Xencor, Inc. |
Fc variants
|
US20090010920A1
(en)
|
2003-03-03 |
2009-01-08 |
Xencor, Inc. |
Fc Variants Having Decreased Affinity for FcyRIIb
|
CA2521414A1
(en)
|
2003-04-02 |
2004-10-21 |
Celator Pharmaceuticals, Inc. |
Methods to individualize combination therapy
|
GB2400851B
(en)
|
2003-04-25 |
2004-12-15 |
Bioinvent Int Ab |
Identifying binding of a polypeptide to a polypeptide target
|
GB2401040A
(en)
|
2003-04-28 |
2004-11-03 |
Chugai Pharmaceutical Co Ltd |
Method for treating interleukin-6 related diseases
|
KR100973564B1
(ko)
|
2003-05-02 |
2010-08-03 |
젠코어 인코포레이티드 |
최적화된 Fc 변이체 및 그의 제조 방법
|
US6921978B2
(en)
|
2003-05-08 |
2005-07-26 |
International Business Machines Corporation |
Method to generate porous organic dielectric
|
NZ621449A
(en)
|
2003-05-30 |
2015-07-31 |
Genentech Inc |
Treatment with anti-vegf antibodies
|
JP2007526220A
(ja)
|
2003-06-05 |
2007-09-13 |
ジェネンテック・インコーポレーテッド |
B細胞疾患の併用療法
|
JP4794301B2
(ja)
|
2003-06-11 |
2011-10-19 |
中外製薬株式会社 |
抗体の製造方法
|
JP2005053541A
(ja)
|
2003-08-05 |
2005-03-03 |
Toppan Printing Co Ltd |
紙容器用積層材料及びそれを用いた紙容器
|
JPWO2005023301A1
(ja)
|
2003-09-04 |
2006-11-02 |
中外製薬株式会社 |
胆管癌治療剤および検出薬
|
US7297336B2
(en)
|
2003-09-12 |
2007-11-20 |
Baxter International Inc. |
Factor IXa specific antibodies displaying factor VIIIa like activity
|
AU2003271174A1
(en)
|
2003-10-10 |
2005-04-27 |
Chugai Seiyaku Kabushiki Kaisha |
Double specific antibodies substituting for functional protein
|
US20080075712A1
(en)
|
2003-10-14 |
2008-03-27 |
Kunihiro Hattori |
Double Specific Antibodies Substituting For Functional Proteins
|
AU2004290070A1
(en)
|
2003-11-12 |
2005-05-26 |
Biogen Idec Ma Inc. |
Neonatal Fc receptor (FcRn)-binding polypeptide variants, dimeric Fc binding proteins and methods related thereto
|
WO2005063815A2
(en)
|
2003-11-12 |
2005-07-14 |
Biogen Idec Ma Inc. |
Fcϝ receptor-binding polypeptide variants and methods related thereto
|
LT2418220T
(lt)
|
2003-12-10 |
2017-10-10 |
E. R. Squibb & Sons, L.L.C. |
Interferono-alfa antikūnai ir jų panaudojimas
|
WO2005062916A2
(en)
|
2003-12-22 |
2005-07-14 |
Centocor, Inc. |
Methods for generating multimeric molecules
|
US20050266425A1
(en)
|
2003-12-31 |
2005-12-01 |
Vaccinex, Inc. |
Methods for producing and identifying multispecific antibodies
|
ES2362667T3
(es)
|
2004-01-09 |
2011-07-11 |
Pfizer Inc. |
ANTICUERPOS FRENTE A MAdCAM.
|
ITBO20040008U1
(it)
|
2004-02-03 |
2004-05-03 |
Tonazzi S R L |
Macchina per il riempimento e la chiusura di tubetti
|
WO2005092925A2
(en)
|
2004-03-24 |
2005-10-06 |
Xencor, Inc. |
Immunoglobulin variants outside the fc region
|
JP4223981B2
(ja)
|
2004-03-24 |
2009-02-12 |
学校法人東海大学 |
ホルムアルデヒド検知材料およびその製造方法
|
WO2005112564A2
(en)
|
2004-04-15 |
2005-12-01 |
The Government Of The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services |
Germline and sequence variants of humanized antibodies and methods of making and using them
|
EP1742061A4
(en)
|
2004-04-28 |
2007-11-21 |
Perseus Proteomics Inc |
MEDIUM FOR PREDICTING AND EVALUATING THE REACTION OF LIVER CANCER AFTER TREATMENT
|
EA010350B1
(ru)
|
2004-06-03 |
2008-08-29 |
Новиммун С.А. |
Антитела против cd3 и способы их применения
|
JP2008501677A
(ja)
|
2004-06-04 |
2008-01-24 |
ファイザー・プロダクツ・インク |
異常な細胞増殖を治療する方法
|
KR100620554B1
(ko)
|
2004-06-05 |
2006-09-06 |
한국생명공학연구원 |
Tag-72에 대한 인간화 항체
|
AR049390A1
(es)
|
2004-06-09 |
2006-07-26 |
Wyeth Corp |
Anticuerpos contra la interleuquina-13 humana y usos de los mismos
|
US20060019342A1
(en)
|
2004-06-25 |
2006-01-26 |
Medimmune, Inc. |
Increasing the production of recombinant antibodies in mammalian cells by site-directed mutagenesis
|
DE102004032634A1
(de)
|
2004-07-06 |
2006-02-16 |
Sms Demag Ag |
Verfahren und Einrichtung zum Messen und Regeln der Planheit und/oder der Bandspannungen eines Edelstahlbandes oder einer Edelstahlfolie beim Kaltwalzen in einem Vielwalzengerüst, insbesondere in einem 20-Walzen-Sendizimir-Walzwerk
|
ATE486610T1
(de)
*
|
2004-07-09 |
2010-11-15 |
Chugai Pharmaceutical Co Ltd |
Anti-glypican-3-antikörper
|
JP4331227B2
(ja)
|
2004-07-09 |
2009-09-16 |
中外製薬株式会社 |
抗グリピカン3抗体
|
SI2471813T1
(sl)
|
2004-07-15 |
2015-03-31 |
Xencor, Inc. |
Optimirane Fc variante
|
CN101001873B
(zh)
|
2004-08-04 |
2013-03-13 |
曼璀克生物科技有限责任公司 |
Fc区变体
|
AU2005277641A1
(en)
|
2004-08-16 |
2006-03-02 |
Medimmune, Llc |
Eph receptor Fc variants with enhanced antibody dependent cell-mediated cytotoxicity activity
|
PT1800693E
(pt)
|
2004-08-24 |
2013-08-23 |
Chugai Pharmaceutical Co Ltd |
Terapia adjuvante utilizando anticorpo antiglipicana
|
JP2008511337A
(ja)
|
2004-09-02 |
2008-04-17 |
ジェネンテック・インコーポレーテッド |
ヘテロ多量体分子
|
WO2006031825A2
(en)
|
2004-09-13 |
2006-03-23 |
Macrogenics, Inc. |
Humanized antibodies against west nile virus and therapeutic and prophylactic uses thereof
|
EP1799718A1
(en)
|
2004-09-14 |
2007-06-27 |
National Institute for Biological Standards and Control (NIBSC) |
Vaccine
|
US20060074225A1
(en)
|
2004-09-14 |
2006-04-06 |
Xencor, Inc. |
Monomeric immunoglobulin Fc domains
|
US7563443B2
(en)
|
2004-09-17 |
2009-07-21 |
Domantis Limited |
Monovalent anti-CD40L antibody polypeptides and compositions thereof
|
CN101068836B
(zh)
|
2004-10-26 |
2013-08-14 |
中外制药株式会社 |
糖链改变的抗磷脂酰肌醇聚糖3抗体
|
US7462697B2
(en)
|
2004-11-08 |
2008-12-09 |
Epitomics, Inc. |
Methods for antibody engineering
|
JP2008524247A
(ja)
|
2004-12-15 |
2008-07-10 |
エラン ファーマ インターナショナル リミテッド |
認知の改善における使用のためのアミロイドβ抗体
|
US20090061485A1
(en)
|
2004-12-22 |
2009-03-05 |
Chugai Seiyaku Kabushiki Kaisha |
Method of Producing an Antibody Using a Cell in Which the Function of Fucose Transporter Is Inhibited
|
EP1838736B1
(en)
|
2005-01-05 |
2013-03-06 |
Biogen Idec MA Inc. |
Cripto binding molecules
|
AU2006204791A1
(en)
|
2005-01-12 |
2006-07-20 |
Xencor, Inc |
Antibodies and Fc fusion proteins with altered immunogenicity
|
AU2006220709B2
(en)
|
2005-03-04 |
2012-09-06 |
Biogen Ma Inc. |
Methods of humanizing immunoglobulin variable regions through rational modification of complementarity determining residues
|
AU2006230413B8
(en)
|
2005-03-31 |
2011-01-20 |
Xencor, Inc |
Fc variants with optimized properties
|
US9493569B2
(en)
|
2005-03-31 |
2016-11-15 |
Chugai Seiyaku Kabushiki Kaisha |
Structural isomers of sc(Fv)2
|
JP5620626B2
(ja)
|
2005-03-31 |
2014-11-05 |
中外製薬株式会社 |
会合制御によるポリペプチド製造方法
|
EP2824183B1
(en)
*
|
2005-04-08 |
2020-07-29 |
Chugai Seiyaku Kabushiki Kaisha |
Methods for producing bispecific antibodies
|
JP5047947B2
(ja)
|
2005-05-05 |
2012-10-10 |
デューク ユニバーシティ |
自己免疫疾患のための抗cd19抗体治療
|
AU2006256041B2
(en)
|
2005-06-10 |
2012-03-29 |
Chugai Seiyaku Kabushiki Kaisha |
Stabilizer for protein preparation comprising meglumine and use thereof
|
JP5224580B2
(ja)
|
2005-06-10 |
2013-07-03 |
中外製薬株式会社 |
sc(Fv)2部位特異的変異体
|
EP1899477A4
(en)
|
2005-07-01 |
2010-01-20 |
Medimmune Inc |
INTEGRATED APPROACH FOR GENERATING MULTIDOMAIN PROTEIN THERAPEUTIC APPLICATIONS
|
EP1921078B1
(en)
|
2005-08-05 |
2013-01-09 |
Chugai Seiyaku Kabushiki Kaisha |
Multikinase inhibitor
|
EP2407486B1
(en)
|
2005-08-19 |
2017-11-22 |
Wyeth LLC |
Antagonist antibodies against GDF-8 and uses in treatment of ALS and other GDF-8-associated disorders
|
WO2007030571A2
(en)
|
2005-09-06 |
2007-03-15 |
Molecular Image Inc. |
Identification of targets and development of reagents for testing and molecular imaging of human disease
|
JP2007093274A
(ja)
|
2005-09-27 |
2007-04-12 |
Perseus Proteomics Inc |
癌の診断方法および治療薬
|
US20070087005A1
(en)
|
2005-10-14 |
2007-04-19 |
Lazar Gregory A |
Anti-glypican-3 antibody
|
WO2007053573A2
(en)
|
2005-10-31 |
2007-05-10 |
Bayer Pharmaceuticals Corporation |
Treatment of cancer with sorafenib
|
WO2007059111A2
(en)
|
2005-11-14 |
2007-05-24 |
Entremed, Inc. |
Anti-angiogenic activity of 2-methoxyestradiol in combination with anti-cancer agents
|
WO2007060411A1
(en)
|
2005-11-24 |
2007-05-31 |
Ucb Pharma S.A. |
Anti-tnf alpha antibodies which selectively inhibit tnf alpha signalling through the p55r
|
BRPI0619056A2
(pt)
|
2005-11-28 |
2011-09-20 |
Genmab As |
anticorpo monovalente, método para preparar e produzir um antcorpo monovalente, construção de ácido nucleico, célula hospedeira, imunoconjugado, uso de um anticorpo monovalente, e, composição farmacêutica
|
US7723043B2
(en)
|
2006-01-04 |
2010-05-25 |
Picobella, Lp |
Methods for screening for prostate cancer
|
CN101415422B
(zh)
|
2006-02-09 |
2012-11-07 |
第一三共株式会社 |
抗癌药用组合物
|
EP1820513A1
(en)
|
2006-02-15 |
2007-08-22 |
Trion Pharma Gmbh |
Destruction of tumor cells expressing low to medium levels of tumor associated target antigens by trifunctional bispecific antibodies
|
TW200745163A
(en)
|
2006-02-17 |
2007-12-16 |
Syntonix Pharmaceuticals Inc |
Peptides that block the binding of IgG to FcRn
|
WO2007099988A1
(ja)
|
2006-02-28 |
2007-09-07 |
Kyowa Hakko Kogyo Co., Ltd. |
α-1,6-フコシルトランスフェラーゼ変異体とその用途
|
JP2007256063A
(ja)
|
2006-03-23 |
2007-10-04 |
Seiko Epson Corp |
表示装置、および、電子機器
|
AR060070A1
(es)
|
2006-03-24 |
2008-05-21 |
Merck Patent Gmbh |
Dominios proteicos heterodimericos obtenidos por ingenieria
|
EP4001409A1
(en)
|
2006-03-31 |
2022-05-25 |
Chugai Seiyaku Kabushiki Kaisha |
Methods for controlling blood pharmacokinetics of antibodies
|
US9670269B2
(en)
|
2006-03-31 |
2017-06-06 |
Chugai Seiyaku Kabushiki Kaisha |
Methods of modifying antibodies for purification of bispecific antibodies
|
WO2007137170A2
(en)
|
2006-05-20 |
2007-11-29 |
Seattle Genetics, Inc. |
Anti-glypican-3 antibody drug conjugates
|
NZ573132A
(en)
|
2006-06-06 |
2012-05-25 |
Glaxo Group Ltd |
Administration of anti-cd3 antibodies in the treatment of autoimmune diseases
|
DK2047863T3
(da)
|
2006-06-08 |
2013-09-16 |
Chugai Pharmaceutical Co Ltd |
Middel til forebyggelse eller behandling af inflammatoriske sygdomme
|
WO2007147901A1
(en)
|
2006-06-22 |
2007-12-27 |
Novo Nordisk A/S |
Production of bispecific antibodies
|
GB2440721A
(en)
|
2006-08-11 |
2008-02-13 |
Univ Cambridge Tech |
Composite biomaterial formed by cooling a fluid composition on a porous solid and removing solidified crystals of the liquid carrier
|
JP4463793B2
(ja)
|
2006-10-10 |
2010-05-19 |
浜松ホトニクス株式会社 |
光検出装置
|
US20100034194A1
(en)
|
2006-10-11 |
2010-02-11 |
Siemens Communications Inc. |
Eliminating unreachable subscribers in voice-over-ip networks
|
JPWO2008090960A1
(ja)
|
2007-01-24 |
2010-05-20 |
協和発酵キリン株式会社 |
ガングリオシドgm2に特異的に結合する遺伝子組換え抗体組成物
|
AU2008230795B2
(en)
*
|
2007-03-27 |
2014-05-29 |
Bioassets, Llc |
Constructs and libraries comprising antibody surrogate light chain sequences
|
CN104497143B
(zh)
|
2007-03-29 |
2020-08-25 |
健玛保 |
双特异性抗体及其制造方法
|
US20100267934A1
(en)
|
2007-05-31 |
2010-10-21 |
Genmab A/S |
Stable igg4 antibodies
|
BRPI0813966A8
(pt)
|
2007-06-29 |
2016-02-10 |
Schering Corp |
Usos de mdl-1
|
PT2178921E
(pt)
|
2007-07-17 |
2016-03-23 |
Squibb & Sons Llc |
Anticorpos monoclonais contra glipicano-3
|
BRPI0817250A2
(pt)
|
2007-09-26 |
2014-06-17 |
Chugai Pharmaceutical Co Ltd |
Anticorpo anti-receptor da il-6.
|
DK2202245T3
(en)
|
2007-09-26 |
2016-11-21 |
Chugai Pharmaceutical Co Ltd |
A method of modifying an antibody isoelectric point VIA amino acid substitution in CDR
|
KR102467302B1
(ko)
|
2007-09-26 |
2022-11-14 |
추가이 세이야쿠 가부시키가이샤 |
항체 정상영역 개변체
|
EP2584043A3
(en)
|
2007-09-28 |
2013-10-02 |
Chugai Seiyaku Kabushiki Kaisha |
Anti-glypican 3 antibody having improved kinetics in plasma
|
WO2009053368A1
(en)
|
2007-10-22 |
2009-04-30 |
Merck Serono S.A. |
Single ifn-beta fused to a mutated igg fc fragment
|
US20090162359A1
(en)
|
2007-12-21 |
2009-06-25 |
Christian Klein |
Bivalent, bispecific antibodies
|
US8242247B2
(en)
|
2007-12-21 |
2012-08-14 |
Hoffmann-La Roche Inc. |
Bivalent, bispecific antibodies
|
PL2235064T3
(pl)
|
2008-01-07 |
2016-06-30 |
Amgen Inc |
Sposób otrzymywania cząsteczek przeciwciał z heterodimerycznymi fc z zastosowaniem kierujących efektów elektrostatycznych
|
TW200949248A
(en)
|
2008-03-17 |
2009-12-01 |
Univ Miyazaki |
Method for detection of liver cancer cell using anti-glypican-3 antibody
|
WO2009120922A2
(en)
|
2008-03-27 |
2009-10-01 |
Zymogenetics, Inc. |
Compositions and methods for inhibiting pdgfrbeta and vegf-a
|
CL2009000647A1
(es)
|
2008-04-04 |
2010-06-04 |
Chugai Pharmaceutical Co Ltd |
Composicion farmaceutica para tratar o prevenir cancer hepatico que comprende una combinacion de un agente quimioterapeutico y un anticuerpo anti-glipicano 3; agente para atenuar un efecto secundario que comprende dicho anticuerpo; metodo para tratar o prevenir un cancer hepatico de un sujeto.
|
EP3521311A1
(en)
|
2008-04-11 |
2019-08-07 |
Chugai Seiyaku Kabushiki Kaisha |
Antigen-binding molecule capable of binding to two or more antigen molecules repeatedly
|
CN101377506A
(zh)
|
2008-04-16 |
2009-03-04 |
北京科美东雅生物技术有限公司 |
磷脂酰肌醇蛋白聚糖-3化学发光免疫分析测定试剂盒及其制备方法
|
SG190572A1
(en)
|
2008-04-29 |
2013-06-28 |
Abbott Lab |
Dual variable domain immunoglobulins and uses thereof
|
KR20110016959A
(ko)
|
2008-06-03 |
2011-02-18 |
아보트 러보러터리즈 |
이원 가변 도메인 면역글로불린 및 이의 용도
|
DE102008042377A1
(de)
|
2008-09-25 |
2010-04-01 |
Robert Bosch Gmbh |
Audioverstärker mit Lastanpassung sowie Verfahren zur Lastanpassung des Audioverstärkers
|
KR20110047255A
(ko)
|
2008-09-26 |
2011-05-06 |
로슈 글리카트 아게 |
이중특이적 항-egfr/항-igf-1r 항체
|
TWI440469B
(zh)
|
2008-09-26 |
2014-06-11 |
Chugai Pharmaceutical Co Ltd |
Improved antibody molecules
|
EA032828B1
(ru)
*
|
2008-10-10 |
2019-07-31 |
Аптево Рисёрч Энд Девелопмент Ллс |
Иммунотерапевтические средства против комплекса tcr
|
DE202008016028U1
(de)
|
2008-12-04 |
2010-04-15 |
Melitta Haushaltsprodukte Gmbh & Co. Kg |
Behälter zur Aufbewahrung von Gegenständen
|
MX2011007833A
(es)
|
2009-01-23 |
2011-10-06 |
Biogen Idec Inc |
Polipeptidos fc estabilizados con funcion efectora reducida y metodos de uso.
|
PE20160651A1
(es)
|
2009-03-05 |
2016-07-24 |
Abbvie Inc |
Proteinas de union a il-17
|
US9228017B2
(en)
|
2009-03-19 |
2016-01-05 |
Chugai Seiyaku Kabushiki Kaisha |
Antibody constant region variant
|
US20120071634A1
(en)
|
2009-03-19 |
2012-03-22 |
Chugai Seiyaku Kabushiki Kaisha |
Antibody Constant Region Variant
|
EP2233500A1
(en)
|
2009-03-20 |
2010-09-29 |
LFB Biotechnologies |
Optimized Fc variants
|
WO2010120561A1
(en)
|
2009-04-01 |
2010-10-21 |
Genentech, Inc. |
Anti-fcrh5 antibodies and immunoconjugates and methods of use
|
PT2417156E
(pt)
|
2009-04-07 |
2015-04-29 |
Roche Glycart Ag |
Anticorpos trivalentes, biespecíficos
|
ES2708124T3
(es)
|
2009-04-27 |
2019-04-08 |
Oncomed Pharm Inc |
Procedimiento para preparar moléculas heteromultiméricas
|
CN103833855A
(zh)
|
2009-06-26 |
2014-06-04 |
瑞泽恩制药公司 |
容易地分离的具有天然免疫球蛋白形式的双特异性抗体
|
NZ598524A
(en)
|
2009-08-29 |
2014-06-27 |
Abbvie Inc |
Therapeutic dll4 binding proteins
|
US10053513B2
(en)
|
2009-11-30 |
2018-08-21 |
Janssen Biotech, Inc. |
Antibody Fc mutants with ablated effector functions
|
JP2011118775A
(ja)
|
2009-12-04 |
2011-06-16 |
Sony Corp |
検索装置、検索方法、及び、プログラム
|
CA2785414C
(en)
|
2009-12-25 |
2019-01-22 |
Tomoyuki Igawa |
Polypeptide modification method for purifying polypeptide multimers
|
CA2791652C
(en)
|
2010-03-02 |
2018-06-12 |
Kyowa Hakko Kirin Co., Ltd. |
Modified antibody composition
|
BR112012022917A2
(pt)
|
2010-03-11 |
2017-01-10 |
Pfizer |
anticorpos com ligação a antígeno dependente de ph
|
TWI667257B
(zh)
|
2010-03-30 |
2019-08-01 |
中外製藥股份有限公司 |
促進抗原消失之具有經修飾的FcRn親和力之抗體
|
WO2011131746A2
(en)
|
2010-04-20 |
2011-10-27 |
Genmab A/S |
Heterodimeric antibody fc-containing proteins and methods for production thereof
|
ES2617777T5
(es)
|
2010-04-23 |
2022-10-13 |
Hoffmann La Roche |
Producción de proteínas heteromultiméricas
|
US9527926B2
(en)
|
2010-05-14 |
2016-12-27 |
Rinat Neuroscience Corp. |
Heterodimeric proteins and methods for producing and purifying them
|
CN103154035B
(zh)
|
2010-05-27 |
2017-05-10 |
根马布股份公司 |
针对her2的单克隆抗体
|
AU2011288412A1
(en)
|
2010-08-13 |
2013-02-21 |
Medimmune Limited |
Monomeric polypeptides comprising variant Fc regions and methods of use
|
EP2635607B1
(en)
|
2010-11-05 |
2019-09-04 |
Zymeworks Inc. |
Stable heterodimeric antibody design with mutations in the fc domain
|
EP4303236A3
(en)
|
2010-11-30 |
2024-03-20 |
Chugai Seiyaku Kabushiki Kaisha |
Cytotoxicity-inducing therapeutic agent
|
SG10201609665PA
(en)
|
2011-02-25 |
2017-01-27 |
Chugai Pharmaceutical Co Ltd |
FcɣRIIb-SPECIFIC Fc ANTIBODY
|
WO2012145469A1
(en)
|
2011-04-19 |
2012-10-26 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Human monoclonal antibodies specific for glypican-3 and use thereof
|
TW201817745A
(zh)
|
2011-09-30 |
2018-05-16 |
日商中外製藥股份有限公司 |
具有促進抗原清除之FcRn結合域的治療性抗原結合分子
|
WO2013047748A1
(ja)
|
2011-09-30 |
2013-04-04 |
中外製薬株式会社 |
複数の生理活性を有する抗原の消失を促進する抗原結合分子
|
SI2771364T1
(sl)
|
2011-10-27 |
2019-10-30 |
Genmab As |
Produkcija heterodimernih proteinov
|
CA2853230C
(en)
|
2011-10-31 |
2021-11-23 |
Chugai Seiyaku Kabushiki Kaisha |
Antigen-binding molecule having regulated conjugation between heavy-chain and light-chain
|
JP6326371B2
(ja)
|
2011-11-04 |
2018-05-16 |
ザイムワークス,インコーポレイテッド |
Fcドメインにおける変異を有する安定なヘテロ二量体抗体デザイン
|
CN113527469A
(zh)
|
2012-02-09 |
2021-10-22 |
中外制药株式会社 |
抗体的Fc区变异体
|
GB201203051D0
(en)
|
2012-02-22 |
2012-04-04 |
Ucb Pharma Sa |
Biological products
|
WO2013127465A1
(en)
|
2012-03-02 |
2013-09-06 |
Roche Glycart Ag |
Predicitive biomarker for cancer treatment with adcc enhanced antibodies
|
MX366813B
(es)
*
|
2012-04-20 |
2019-07-25 |
Aptevo Res & Development Llc |
Polipeptidos de enlace cd3.
|
CN114163530A
(zh)
|
2012-04-20 |
2022-03-11 |
美勒斯公司 |
用于产生免疫球蛋白样分子的方法和手段
|
SG11201407972RA
(en)
*
|
2012-06-01 |
2015-01-29 |
Us Health |
High-affinity monoclonal antibodies to glypican-3 and use thereof
|
KR20150041662A
(ko)
|
2012-08-13 |
2015-04-16 |
리제너론 파아마슈티컬스, 인크. |
Ph-의존적 결합 특성을 갖는 항-pcsk9 항체
|
PL2900694T3
(pl)
*
|
2012-09-27 |
2018-12-31 |
Merus N.V. |
Dwuswoiste przeciwciała igg jako aktywatory komórek t
|
ES2773107T3
(es)
|
2012-10-05 |
2020-07-09 |
Kyowa Kirin Co Ltd |
Composición de proteína heterodimérica
|
AU2013337578C1
(en)
|
2012-11-02 |
2018-04-12 |
Zymeworks Inc. |
Crystal structures of heterodimeric Fc domains
|
CN103833852A
(zh)
|
2012-11-23 |
2014-06-04 |
上海市肿瘤研究所 |
针对磷脂酰肌醇蛋白多糖-3和t细胞抗原的双特异性抗体
|
TWI693073B
(zh)
|
2012-12-21 |
2020-05-11 |
日商中外製藥股份有限公司 |
對gpc3標的治療劑療法為有效之患者投與的gpc3標的治療劑
|
RU2758952C1
(ru)
|
2013-09-27 |
2021-11-03 |
Чугаи Сейяку Кабусики Кайся |
Способ получения полипептидного гетеромультимера
|
EP3940065A1
(en)
|
2013-09-30 |
2022-01-19 |
Chugai Seiyaku Kabushiki Kaisha |
Method for producing antigen-binding molecule using modified helper phage
|
NZ724710A
(en)
|
2014-04-07 |
2024-02-23 |
Chugai Pharmaceutical Co Ltd |
Immunoactivating antigen-binding molecule
|
CN106459959A
(zh)
|
2014-05-08 |
2017-02-22 |
中外制药株式会社 |
对gpc3靶向治疗剂疗法有效的患者施用的gpc3靶向治疗剂
|
TW201623333A
(zh)
|
2014-05-13 |
2016-07-01 |
Chugai Pharmaceutical Co Ltd |
對具有免疫抑制機能之細胞的t細胞重定向抗原結合分子
|
MA40764A
(fr)
*
|
2014-09-26 |
2017-08-01 |
Chugai Pharmaceutical Co Ltd |
Agent thérapeutique induisant une cytotoxicité
|
NZ730607A
(en)
|
2014-12-19 |
2022-07-01 |
Chugai Pharmaceutical Co Ltd |
Anti-myostatin antibodies, polypeptides containing variant fc regions, and methods of use
|
ES2899894T3
(es)
|
2014-12-19 |
2022-03-15 |
Chugai Pharmaceutical Co Ltd |
Anticuerpos anti-C5 y métodos de uso
|
EA201791754A1
(ru)
|
2015-02-05 |
2019-01-31 |
Чугаи Сейяку Кабусики Кайся |
АНТИТЕЛА, СОДЕРЖАЩИЕ ЗАВИСЯЩИЙ ОТ КОНЦЕНТРАЦИИ ИОНОВ АНТИГЕНСВЯЗЫВАЮЩИЙ ДОМЕН, ВАРИАНТЫ Fc-ОБЛАСТИ, IL-8-СВЯЗЫВАЮЩИЕ АНТИТЕЛА И ИХ ПРИМЕНЕНИЯ
|
JP7082484B2
(ja)
|
2015-04-01 |
2022-06-08 |
中外製薬株式会社 |
ポリペプチド異種多量体の製造方法
|
CN117205314A
(zh)
|
2016-03-14 |
2023-12-12 |
中外制药株式会社 |
用于癌症治疗的诱导细胞损伤的治疗药物
|
MX2018010988A
(es)
*
|
2016-03-14 |
2019-01-21 |
Chugai Pharmaceutical Co Ltd |
Farmaco terapeutico que induce lesion celular para usarse en terapia de cancer.
|